First Time Loading...

Minerva Neurosciences Inc
NASDAQ:NERV

Watchlist Manager
Minerva Neurosciences Inc Logo
Minerva Neurosciences Inc
NASDAQ:NERV
Watchlist
Price: 2.37 USD 0.85% Market Closed
Updated: May 5, 2024

Minerva Neurosciences Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Minerva Neurosciences Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Minerva Neurosciences Inc
NASDAQ:NERV
Cash from Financing Activities
$19.6m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
18%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is Minerva Neurosciences Inc's Cash from Financing Activities?
Cash from Financing Activities
19.6m USD

Based on the financial report for Dec 31, 2023, Minerva Neurosciences Inc's Cash from Financing Activities amounts to 19.6m USD.

What is Minerva Neurosciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
18%

The average annual Cash from Financing Activities growth rates for Minerva Neurosciences Inc have been 14% over the past three years , and 18% over the past ten years .